[go: up one dir, main page]

AU2001266562A1 - Cerebellin homologous polypeptides and therapeutic uses thereof - Google Patents

Cerebellin homologous polypeptides and therapeutic uses thereof

Info

Publication number
AU2001266562A1
AU2001266562A1 AU2001266562A AU6656201A AU2001266562A1 AU 2001266562 A1 AU2001266562 A1 AU 2001266562A1 AU 2001266562 A AU2001266562 A AU 2001266562A AU 6656201 A AU6656201 A AU 6656201A AU 2001266562 A1 AU2001266562 A1 AU 2001266562A1
Authority
AU
Australia
Prior art keywords
cerebellin
therapeutic uses
homologous polypeptides
homologous
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266562A
Inventor
Eric Wen Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2001266562A1 publication Critical patent/AU2001266562A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2001266562A 2000-06-23 2001-06-11 Cerebellin homologous polypeptides and therapeutic uses thereof Abandoned AU2001266562A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21394400P 2000-06-23 2000-06-23
US60213944 2000-06-23
PCT/US2001/014843 WO2002000709A2 (en) 2000-06-23 2001-06-11 Cerebellin homologous polypeptides and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
AU2001266562A1 true AU2001266562A1 (en) 2002-01-08

Family

ID=22797138

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266562A Abandoned AU2001266562A1 (en) 2000-06-23 2001-06-11 Cerebellin homologous polypeptides and therapeutic uses thereof

Country Status (4)

Country Link
US (1) US20030216547A1 (en)
EP (1) EP1297008A2 (en)
AU (1) AU2001266562A1 (en)
WO (1) WO2002000709A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009040069A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of bq-610 alone or in combination with helodermin as a therapeutic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042576A1 (en) * 1998-02-23 1999-08-26 Smithkline Beecham Plc Cerebellin-2 related polypeptides and dna coding therefor
CA2339043A1 (en) * 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
AU2883700A (en) * 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030139358A1 (en) * 2000-05-05 2003-07-24 Spytek Kimberly A. Novel human proteins, polynucleotides encoding them and methods of using the same

Also Published As

Publication number Publication date
WO2002000709A3 (en) 2002-06-20
US20030216547A1 (en) 2003-11-20
EP1297008A2 (en) 2003-04-02
WO2002000709A2 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2001296981A1 (en) Chair control
AU2001260327A1 (en) Chair
AU2001287023A1 (en) Plasma-derived-fibrin-based matrices and tissue
AU9153601A (en) Portable sauna
AU2002211717A1 (en) Stresscopins and their uses
AU2001290078A1 (en) Stem cell therapy
AU2001259837A1 (en) Therapeutic pore-forming peptides
AU2001292574A1 (en) Human phermone polypeptide
AU2002227925A1 (en) Human beta-defensin-3
AU5994599A (en) Rbp1 polypeptides and uses thereof
AU2001275723A1 (en) Bougie
AU2001280464A1 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
AU2001252200A1 (en) Chair
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001285183A1 (en) Human phermone polypeptides
AU2001256977A1 (en) Human sez6 nucleic acids and polypeptides
AU2001266562A1 (en) Cerebellin homologous polypeptides and therapeutic uses thereof
AU2002218199A1 (en) Truncated phosphodiesterase-7 polypeptides
AU2001277519A1 (en) Bio-probes and use thereof
AU2001263287A1 (en) Human protein kinase "13305" and uses therefor
AU2001277750A1 (en) Use of polypeptide
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU2002215030A1 (en) Chair